Concord Drugs Ltd - 538965 - Intimation Of Book Closure For The Purpose Of 28Th Annual General Meeting
Intimation of Book Closure for the purpose of 28th Annual General Meeting08-09-2023
08-09-2023
Concord Drugs Ltd - 538965 - Shareholder''s Meeting - AGM On 30.09.2023
Shareholder''s Meeting - AGM on 30.09.202308-09-2023
Concord Drugs Ltd - 538965 - Outcome Of Board Meeting Held On 07.09.2023
Outcome of Board Meeting held on 07.09.202307-09-2023
Concord Drugs Ltd - 538965 - Penalty Imposed By SEBI On The Company, Directors Etc.,
Penalty imposed by SEBI on the Company, Directors, etc.,23-08-2023
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication17-08-2023
Concord Drugs Ltd - 538965 - Statement Of Deviation/Variation For The Quarter Ended 30.06.2023
Statement of Deviation/Variation for the quarter ended 30.06.202314-08-2023
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Un-Audited Financial Results (Both Standalone And Consolidated) For The Quarter Ended 30.06.2023
Un-audited Financial Results (both Standalone and Consolidated) for the quarter ended 30.06.202314-08-2023
Concord Drugs Ltd - 538965 - Un-Audited Financial Results (Both Standalone And Consolidated) For The Quarter Ended 30.06.2023
Un-audited Financial Results (both Standalone and Consolidated) for the quarter ended 30.06.202314-08-2023
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30.06.2023
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30.06.202305-08-2023